Patent Box and R&D Deduction: The Swiss Tax Relief Innovative SMEs Overlook

Many innovative Swiss SMEs pay more cantonal tax than they need to, because they assume the patent box and the research and development super-deduction are instruments for large corporations. They are not. Both were built into ordinary cantonal tax law by the 2020 tax reform, and a MedTech, hardware, software or manufacturing SME with genuine Swiss R&D can use them to cut its cantonal tax bill, often without changing anything about how it operates.

The Federal Act on Tax Reform and AHV Financing (TRAF), in force since 1 January 2020, gave the cantons two innovation instruments: a mandatory patent box and an optional additional deduction for R&D expenditure (Source: Swiss Tax Harmonisation Act, StHG Art. 24a and Art. 25a). Both reduce cantonal and communal income tax only, not the federal corporate tax, and both are capped by an overall relief limit. This article explains how each works, who actually qualifies, and what a Swiss SME must do to claim them.

The two innovation instruments TRAF gave Swiss SMEs

TRAF replaced the abolished special tax regimes with two targeted reliefs: the patent box for income from registered IP, and the R&D super-deduction for the cost of doing research in Switzerland.

They work at different points. The patent box reduces the tax on the profit that qualifying patents generate, so it rewards the output of innovation. The R&D super-deduction increases the tax deduction for what you spend on research, so it rewards the input. A company can use one, the other, or both, subject to an overall cap. Crucially, the patent box is mandatory in every canton, while the R&D deduction is optional, so whether it is available and at what rate depends on your canton (Source: StHG Art. 24a, 25a). Neither touches the direct federal tax, whose headline rate is 8.5% and whose effective burden is 7.83% of pre-tax profit because the tax is itself deductible.

The patent box: how it works

The patent box exempts up to 90% of the net profit from qualifying patents and comparable rights from cantonal and communal income tax.

Mechanics. Under StHG Art. 24a, the net income attributable to qualifying patents is, on application, taxed at the cantonal level with a reduction of up to 90%, so as little as 10% of that patent income enters the cantonal tax base. The exact reduction is set by each canton up to that 90% ceiling. Before the reduction applies, the qualifying income is scaled by a nexus ratio in line with the OECD standard: the share of qualifying income eligible for the box reflects the proportion of the R&D for that patent that was carried out by the company in Switzerland, relative to total R&D for it (Source: StHG Art. 24a; OECD BEPS Action 5 modified nexus approach). The more of the underlying research you did in Switzerland, the more of the patent income qualifies.

Who actually qualifies for the patent box

The patent box is only for income from registered rights, which means it fits IP-owning SMEs in fields like MedTech, hardware, biotech and manufacturing, and excludes most pure-service businesses.

Qualifying rights are patents and comparable registered rights such as supplementary protection certificates, topographies and plant variety rights, and in a few cantons, under narrow conditions, copyright-protected software (Source: StHG Art. 24a; cantonal practice). A trademark or an unregistered process does not qualify. This is the key filter for an SME: if your product embeds a patented invention, you may have qualifying income; if your value is a service, a brand or know-how without a registered patent, the box will generally not apply. Because the relief attaches to registered IP, the practical first question is whether your innovation is, or could be, protected by a patent rather than kept as an unregistered trade secret. That is a strategic decision with tax consequences, and it belongs in the same conversation as your IP and corporate tax planning.

The R&D super-deduction: broader and often overlooked

The R&D super-deduction lets a canton grant an additional deduction of up to 50% on qualifying research costs incurred in Switzerland, and unlike the patent box it does not require any registered IP.

Under StHG Art. 25a, cantons may allow an increased deduction of up to 50% above the R&D expense actually booked, calculated principally on R&D personnel costs performed in Switzerland, plus a statutory surcharge for other research costs. Because it is tied to spending rather than to a patent, it reaches a far wider circle of companies: a manufacturing SME improving a production process, or a software company with a Swiss development team, can qualify even without a single patent. Two conditions matter. First, the research must be physically carried out in Switzerland; work done abroad is not eligible. Second, because the deduction is optional, you must check whether your canton grants it and at what rate, as not every canton has adopted the full 50%. Tracking R&D personnel costs cleanly in your accounting records is what makes the claim defensible.

The 70% relief cap: you always pay tax on at least 30% of profit

Switzerland limits the total benefit: the patent box, the R&D super-deduction and related reliefs together may not reduce taxable profit by more than 70% in a year.

Under StHG Art. 25b, the combined relief from the patent box, the additional R&D deduction and certain other items is capped so that at least 30% of the cantonal taxable profit always remains taxable, and the relief cannot create or increase a loss. This is a deliberate floor: the instruments are designed to reward genuine Swiss innovation, not to eliminate a company’s tax bill entirely. For planning, it means the reliefs reduce, rather than remove, cantonal tax, and the exact benefit depends on your profit mix, your canton’s rates and how much of your income and R&D actually qualifies.

A worked illustration

The value of the reliefs is easiest to see with a simple example, using assumed figures you should replace with your own.

Illustrative example, using assumed figures you should replace with your own: an SME has CHF 1’000’000 of cantonal taxable profit, of which CHF 400’000 is net income from a qualifying patent, and the company did all the underlying research in Switzerland, so the nexus ratio is 100%. If its canton grants the full 90% patent-box reduction, CHF 360’000 of that patent income (90% of CHF 400’000) is removed from the cantonal base, subject to the overall 70% cap. Separately, if the company spent CHF 200’000 on qualifying Swiss R&D personnel and its canton grants a 50% additional deduction, it can deduct a further CHF 100’000. The combined relief is then tested against the 70% cap on the CHF 1’000’000 profit, meaning at least CHF 300’000 remains taxable at cantonal level. The federal tax is unaffected throughout. These are arithmetic illustrations on assumed inputs and cantonal rates you must confirm, not a forecast for your business.

What Swiss SMEs should do to claim the reliefs

Claiming the reliefs is a matter of preparation: protect the IP, track the costs, confirm your canton’s rules, and consider a ruling.

Start by reviewing whether your innovation is protected by a registered patent, since without one the patent box is unavailable even if the product is genuinely inventive. Track R&D personnel costs and project time in your accounts so that qualifying expenditure can be evidenced, because both the nexus calculation and the R&D deduction rely on clean cost data. Confirm what your specific canton grants, as the patent-box reduction and the R&D deduction both vary within the statutory ceilings. For a first-time patent-box entry, the transitional taxation of past R&D expenses and the nexus documentation are technical, so an advance tax ruling with the cantonal administration is often worthwhile to fix the treatment before you file. Because these are cantonal reliefs applied through your corporate tax return, they reward companies that plan ahead of the filing rather than discover the opportunity afterwards.

Frequently Asked Questions

Are the patent box and R&D deduction only for large companies?

No. Both are part of ordinary cantonal tax law under the 2020 TRAF reform and are available to SMEs. They are unrelated to the OECD Pillar Two minimum tax, which only applies to groups above EUR 750 million in revenue. A small Swiss company with a qualifying patent or genuine Swiss R&D can use them.

How much can the patent box reduce my tax?

The patent box reduces the cantonal and communal tax on qualifying patent income by up to 90%, subject to a nexus ratio reflecting how much of the research was done in Switzerland, and to an overall relief cap of 70% of taxable profit (Source: StHG Art. 24a, 25b). It does not reduce the direct federal tax, and the exact reduction depends on your canton.

Do I need a patent to claim the R&D super-deduction?

No. The R&D super-deduction under StHG Art. 25a is tied to research spending, not to registered IP, so a company with a Swiss development or engineering team can qualify without any patent. The research must be carried out in Switzerland, and the deduction is optional per canton, so confirm your canton grants it.

Which cantons offer the R&D super-deduction?

The patent box is mandatory in every canton, but the additional R&D deduction is optional, and the rate up to the 50% ceiling varies by canton. You must check the current rules in your canton of tax residence, because availability and the exact percentage differ across Switzerland.

Can these reliefs eliminate my cantonal tax entirely?

No. Under StHG Art. 25b, the combined relief from the patent box, the R&D deduction and related items cannot reduce cantonal taxable profit by more than 70%, so at least 30% always remains taxable, and the relief cannot create a loss. The instruments reduce, but do not remove, cantonal tax.

What records do I need to support a claim?

You need clean documentation of your R&D activities and costs, especially personnel costs by project, and evidence of where the research was performed, since both the patent-box nexus ratio and the R&D deduction depend on qualifying Swiss expenditure. For a first patent-box entry, an advance ruling with your cantonal tax administration can confirm the treatment before filing.

The patent box and R&D super-deduction are among the few tax reliefs written specifically to reward Swiss innovation, yet many eligible SMEs never claim them because they assume the rules are meant for someone bigger. If your company holds a patent or runs genuine research in Switzerland, it is worth checking what your canton allows before your next tax return. Scalemetrics can help you assess eligibility, structure the documentation and coordinate a cantonal ruling so the relief is claimed correctly.

The Nexus Ratio: Why Your Own R&D Spend Sets the Benefit

The patent box does not exempt all patent profit automatically; the modified nexus approach ties the relief to your own research effort. The nexus ratio is qualifying R&D expenditure divided by total R&D expenditure for the patent, capped at 100%. Qualifying expenditure is your own domestic R&D plus contract research you finance, increased by a flat 30% uplift; R&D you buy from related parties abroad does not qualify. Multiply the box profit by that ratio, then apply the cantonal reduction, up to a maximum 90% reduction of the qualifying income.

• Nexus ratio: qualifying R&D divided by total R&D per patent, capped at 100%.
• Qualifying R&D: your own domestic research plus contract research you finance, plus a 30% uplift.
• Does not qualify: core R&D bought from related parties abroad.
• Maximum relief: up to 90% of the qualifying box income, then the cantonal rate applies.

The practical consequence: a company that does its R&D in-house captures close to the full benefit, while one that licenses or outsources core development abroad captures far less. Document R&D spend per patent from the start, because you cannot reconstruct the ratio later. For the claim and the ruling see our corporate tax and VAT compliance service; to track qualifying spend, our budgeting and forecasting service.

How does the nexus ratio affect my Swiss patent box benefit?

The relief equals box profit times the nexus ratio (qualifying R&D divided by total R&D per patent, capped at 100%), then the cantonal reduction up to a maximum 90% of qualifying income. Qualifying R&D is your own domestic research plus contract research you finance, uplifted by a flat 30%; related-party R&D bought abroad does not qualify. In-house R&D captures close to the full benefit.